Status:

COMPLETED

Cervical Carious Lesions Restored With Calcium Silicate Based Cement (Biodentine) Compared With Glass-ionomer Cement

Lead Sponsor:

Jordan University of Science and Technology

Conditions:

Gingivitis

Eligibility:

All Genders

20-60 years

Phase:

NA

Brief Summary

This study will test if applying calcium silicate cements (Biodentine) to restore cervical carious lesions might adversely affect the gingival health in comparison with conventionally used tooth color...

Detailed Description

The study will compare two different dental materials on dental lesions near the gum line. . The study will determine if one material is more effective in gingival health, after the placement of the t...

Eligibility Criteria

Inclusion

  • good general health;
  • good oral hygiene; and
  • age range 18-60 years old.
  • Patients with the following criteria were excluded:
  • current smokers;
  • pregnant females;
  • or patient with periodontal diseases; and
  • those who had a history of poorly controlled diabetes, liver disease, malignancy, radiotherapy.

Exclusion

  • Pregnant women
  • Patients taking benzodiazepines, narcotics and multiple antidepressants for pain management not associated with the oral cavity
  • Patients requiring treatment for more than 5 decayed sites, periodontal disease and root canal therapy
  • Complicated medical history (\>4 concurrent treatment for systemic diseases)
  • Lesion \>1mm below the gum line

Key Trial Info

Start Date :

January 3 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 28 2015

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT03418246

Start Date

January 3 2015

End Date

December 28 2015

Last Update

February 1 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.